| Financial Year |
March 31 2023 |
| Monetary Funds |
604,451,486.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
4,972,442,446.15 |
| Advances to Suppliers |
45,313,057.75 |
| Other Receivables |
36,374,300.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
306,948,252.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,179,714.87 |
| Total Current Assets |
6,026,709,257.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,562,164.91 |
| Investment Properties |
7,271,346.80 |
| Fixed Assetes |
556,488,223.03 |
| Under-construction Projects |
172,754,895.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
216,368,626.80 |
| R&D expenses |
-- |
| Goodwill |
35,832,957.08 |
| Long-Term Deferred and Prepaid Expenses |
357,238.01 |
| Deferred Income Tax Assets |
89,265,473.21 |
| Other Non-Current Assets |
30,000,000.00 |
| Sub-Total of Non-Current Assets |
1,204,396,897.55 |
| Total Assets |
7,231,106,154.63 |
| Short-Term Loans |
846,913,119.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
236,506,530.21 |
| Accounts Received In Advance |
4,176,848.69 |
| Employee Compensation Payable |
41,097,290.66 |
| Taxes Payable |
137,337,543.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,660,259.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
408,427,685.62 |
| Other Current Liabilities |
1,486,012.61 |
| Sub-Total of Current Liabilities |
1,722,036,141.53 |
| Long-term Loans |
2,237,433,769.69 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
604,808,444.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,370,528.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,966,769,640.00 |
| Total Liabilities |
4,688,805,781.53 |
| Paid-In Capital(Or Share Stock) |
838,875,646.00 |
| Capital Surplus |
-- |
| Surplus Reserve |
28,759,920.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,662,359,303.18 |
| Minority Stockholder's Interest |
12,305,503.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,529,994,869.88 |
| Owner's Equity（Stockholder's Equity） |
2,542,300,373.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,231,106,154.63 |
